Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:2222-2227
Published online before print August 25, 2005, doi: 10.1161/01.ATV.0000183605.27125.6f
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/10/2222    most recent
01.ATV.0000183605.27125.6fv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sahni, A.
Right arrow Articles by Francis, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sahni, A.
Right arrow Articles by Francis, C. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:2222.)
© 2005 American Heart Association, Inc.


Thrombosis

Endothelial Cell Activation by IL-1ß in the Presence of Fibrinogen Requires {alpha}Vß3

Abha Sahni; Sanjeev K. Sahni; Charles W. Francis

From Hematology/Oncology Unit, Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, NY.

Correspondence to Abha Sahni, PhD, Department of Medicine, P.O. Box 610, University of Rochester Medical Center, 601 Elmwood Ave, Rochester, NY 14642. E-mail Abha_Sahni{at}urmc.rochester.edu

Objective— The purpose of this study was to investigate the receptor requirements for enhanced IL-1ß–induced secretion of nitric oxide (NO) by endothelial cells (ECs) in the presence of fibrinogen.

Methods and Results— ECs were exposed to IL-1ß with or without fibrinogen and NO was measured as nitrite. NO production by EC exposed to fibrinogen (0.3±0.1 µmol/L) was comparable concentration to control (0.2±0.1 µmol/L), but IL-1ß significantly increased NO production (0.8±0.1 µmol/L), and the combination of both fibrinogen and IL-1ß resulted in a further increase to 2.2±0.2 µmol/L (P<0.002). 7E3 or LM609, antibodies to {alpha}vß3, inhibited NO production stimulated by fibrinogen-bound IL-1ß to 0.2±0.1 µmol/L (P<0.001) or 0.2±0.03 µmol/L (P<0.0001), respectively. These levels were comparable to control and significantly less than with IL-1ß (P<0.002). EC or fibroblasts exposed to both fibrinogen and IL-1ß, but not vitronectin and IL-1ß, demonstrated positive Western blotting for {alpha}Vß3 after immunopurification with anti- IL-1R, indicating specific association between {alpha}vß3 and IL-1R. Dual immunofluorescence also revealed colocalization of {alpha}vß3 and IL-1R only when the cells were exposed to both fibrinogen and IL-1ß.

Conclusion— The enhanced NO production by ECs in the presence of fibrinogen-bound IL-1ß requires the coordinated effects of colocalized {alpha}Vß3 and IL-1R.

The ability of fibrinogen-bound IL-1ß to stimulate NO secretion by ECs is blocked by anti-{alpha}vß3. Also, fibrinogen-bound IL-1ß promotes the specific association of {alpha}vß3 with IL-1R, as shown by coimmunoprecipitation or immunofluorescence staining. Fibrinogen binding enhances IL-1ß–induced secretion of NO through the coordinated effects of colocalized {alpha}vß3 and IL-1R.


Key Words: endothelial cells • fibrinogen • IL-1ß • nitric oxide